Real-World Disparities in Severe Asthma Management: Emergency Utilization, Specialist Visits, and Biologic Treatment
Journal of Allergy and Clinical Immunology: Global · 2026-11 · 100820
DOI: 10.1016/j.jacig.2026.100820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2026-11. Verfasst von Mehmet Furkan Bagci und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline Biologicals SA/NV.
Abstract (Originalsprache)
Background:Asthma disproportionately affects minority and low-income populations, yet patterns of emergency care, specialist access, and biologic therapy across social determinants are not well defined.
Objective
To quantify racial, insurance, and socioeconomic disparities in ED use, specialist visits, and biologic treatment among patients with asthma. Methods:We conducted a retrospective study of patients aged 6-65 years with asthma in the Scripps Health system (San Diego, CA) from 2018-2023.Severe asthma was defined by American Thoracic Society criteria applied to EHR medication and exacerbation data.ED visits, allergy/immunology or pulmonology encounters, and biologic prescriptions were examined by race/ethnicity, insurance, and socioeconomic measures.Disparities were summarized using established inequality indices and two novel metrics, the Biologic Treatment Gap (difference between severe asthma prevalence and biologic use) and the Biologic Coverage (biologic use among patients with severe asthma).Analyses were replicated using aggregated data from the Epic Cosmos national EHR network.
Results
In the regional cohort (N=10,775), 740 patients (6.86%) met EHR-applied ATS-based criteria for severe asthma.ED use was disproportionately high among Black, Hispanic, and Medi-Cal patients.Specialist-visit proportions were lower among Hispanic and Black patients than White patients.Biologic use was low across groups and was lower among Hispanic, Black, and Medi-Cal patients than among White, Asian, and commercially insured patients.Epic Cosmos showed similar patterns, including higher ED use among Black patients (65.2%) and lower biologic use among Hispanic patients (0.84%). Conclusions:We identified substantial racial/ethnic, insurance-related, and socioeconomic inequities across the asthma care cascade, including disproportionate ED utilization, lower specialist engagement for some groups, and low biologic uptake despite severe-asthma burden.These findings support targeted strategies to improve equitable access to guideline-concordant specialty and biologic care for patients facing structural barriers to asthma management. J o u r n a l P r e -p r o o fHighlights and Keywords What is already known about this topic?Asthma disproportionately affects racial and ethnic minorities, Medicaid recipients, and socioeconomically deprived communities, who experience higher emergency department use and worse outcomes yet are less likely to access specialty care or biologic therapy.What does this article add to our knowledge?Using regional and national electronic health record cohorts, we quantify inequities across the asthma care cascade and introduce novel metricsthe Biologic Treatment Gap and Biologic Coverage-to capture biologic underuse relative to severe asthma burden. How does this study impact current management guidelines?Findings support targeted, equity-focused interventions-including improved specialist referral, proactive identification of high-risk patients, and monitoring of disparity metrics-to align biologic use with severe asthma burden in marginalized populations.
Förderung
- GlaxoSmithKline Biologicals SA/NV
Zitieren
APA
Bagci, M. F., Bagsic, S. R. S., Do, T., Ritko, A. L., Nguyen, T., Modena, B. D., & Ozturk, Y. (2026). Real-World Disparities in Severe Asthma Management: Emergency Utilization, Specialist Visits, and Biologic Treatment. Journal of Allergy and Clinical Immunology: Global, 100820. https://doi.org/10.1016/j.jacig.2026.100820
Vancouver
Bagci MF, Bagsic SRS, Do T, Ritko AL, Nguyen T, Modena BD, et al. Real-World Disparities in Severe Asthma Management: Emergency Utilization, Specialist Visits, and Biologic Treatment. Journal of Allergy and Clinical Immunology: Global. 2026:100820. doi:10.1016/j.jacig.2026.100820
BibTeX
@article{Bagci2026,
author = {Bagci, Mehmet Furkan and Bagsic, Samantha R. Spierling and Do, Toan and Ritko, Anna L. and Nguyen, Truong and Modena, Brian D. and Ozturk, Yusuf},
title = {Real-World Disparities in Severe Asthma Management: Emergency Utilization, Specialist Visits, and Biologic Treatment},
journal = {Journal of Allergy and Clinical Immunology: Global},
year = {2026},
pages = {100820},
doi = {10.1016/j.jacig.2026.100820}
}
EUVIMED